The data from these trials will determine not just whether retatrutide gets approved, but how it gets approved, which indications, what doses, and what safety warnings
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept
Yes, GLP-1 receptor agonists can cause diarrheait is one of the most commonly reported gastrointestinal side effects
This short background informs why regulation, physician oversight, and uniform product quality are important for efficacy and safety
Research consistently shows that higher protein consumption, in the range of 1.2g to 1.6g per kilogram of body weight daily, significantly reduces muscle catabolism
The company has launched Liraglutide Injection (18 mg/3 mL) in the U.S., a bioequivalent version of Victoza by Novo Nordisk